Picture of Telo Genomics logo

TELO — Telo Genomics News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: 3D Signatures Signed Collaboration Agreement With Mdxhealth SA To Evaluate Co's Prognostic Test Candidate For Prostate Cancer

March 28 (Reuters) - 3D Signatures Inc  DXD.V :
    * 3D SIGNATURES - SIGNED COLLABORATION AGREEMENT WITH
MDXHEALTH SA
TO EVALUATE CO'S PROGNOSTIC TEST CANDIDATE FOR PROSTATE CANCER
    * 3D SIGNATURES INC - CO, MDXHEALTH WILL SHARE COSTS OF
CONDUCTING
COLLABORATIVE STUDY
    * 3D SIGNATURES - ALSO GRANTED MDXHEALTH EXCLUSIVE OPTION TO
NEGOTIATE A LICENSE AGREEMENT FOR THE PROGNOSTIC TEST CANDIDATE
FOR PROSTATE CANCER

Source text for Eikon:  ID:nGNX6j1w6M 
Further company coverage:  DXD.V 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Telo Genomics

See all news